Trillet-Lenoir V - Search Results

1

Fournel-Federico C, You B, Trillet-Lenoir V. Fournel-Federico C, et al. Rev Prat. 2007 Dec 15;57(19):2093-8. Rev Prat. 2007. PMID: 18303784 Review. French.

2

[Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].

Bompas E, Freyer G, Trillet-Lenoir V. Bompas E, et al. Bull Cancer. 1998 Feb;85(2):125-7. Bull Cancer. 1998. PMID: 9752328 Free article. French. No abstract available.

3

[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient].

Clippe C, Trillet-Lenoir V, Freyer G. Clippe C, et al. Rev Prat. 2003 Jan 15;53(2):187-98. Rev Prat. 2003. PMID: 12664853 Review. French. No abstract available.

4

Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.

You B, Tranchand B, Girard P, Falandry C, Ribba B, Chabaud S, Souquet PJ, Court-Fortune I, Trillet-Lenoir V, Fournel C, Tod M, Freyer G. You B, et al. Lung Cancer. 2008 Nov;62(2):261-72. doi: 10.1016/j.lungcan.2008.03.008. Epub 2008 Apr 28. Lung Cancer. 2008. PMID: 18442869 Clinical Trial.

5

Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab.

Poncet B, Colin C, Bachelot T, Jaisson-Hot I, Derain L, Magaud L, Fournel-Federico C, Mousseau M, Tigaud JD, Jacquin JP, Trillet-Lenoir V. Poncet B, et al. Am J Clin Oncol. 2009 Aug;32(4):369-74. doi: 10.1097/COC.0b013e31818c08d3. Am J Clin Oncol. 2009. PMID: 19381078

6

Chemotherapy may be delivered based on an integrated view of tumour dynamics.

Ribba B, You B, Tod M, Girard P, Tranchand B, Trillet-Lenoir V, Freyer G. Ribba B, et al. IET Syst Biol. 2009 May;3(3):180-90. doi: 10.1049/iet-syb.2008.0104. IET Syst Biol. 2009. PMID: 19449978 Free article.

7

Phase I dose-escalation study of intravenous aflibercept in combination with docetaxel in patients with advanced solid tumors.

Isambert N, Freyer G, Zanetta S, You B, Fumoleau P, Falandry C, Favier L, Assadourian S, Soussan-Lazard K, Ziti-Ljajic S, Trillet-Lenoir V. Isambert N, et al. Clin Cancer Res. 2012 Mar 15;18(6):1743-50. doi: 10.1158/1078-0432.CCR-11-1918. Epub 2012 Jan 18. Clin Cancer Res. 2012. PMID: 22261804 Clinical Trial.

8

Depression assessment by oncologists and palliative care physicians.

Rhondali W, Perceau E, Saltel P, Trillet-Lenoir V, Blay JY, Fournel-Federico C, Coulon JP, Tredan O, Terra JL, Matillon Y, Bruera E, Filbet M. Rhondali W, et al. Palliat Support Care. 2012 Dec;10(4):255-63. doi: 10.1017/S1478951511000988. Epub 2012 May 15. Palliat Support Care. 2012. PMID: 22583756

9

Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours.

Freyer G, Isambert N, You B, Zanetta S, Falandry C, Favier L, Trillet-Lenoir V, Assadourian S, Soussan-Lazard K, Ziti-Ljajic S, Fumoleau P. Freyer G, et al. Br J Cancer. 2012 Aug 7;107(4):598-603. doi: 10.1038/bjc.2012.304. Epub 2012 Jul 12. Br J Cancer. 2012. PMID: 22790797 Free PMC article. Clinical Trial.

10

Hypersensitivity to oxaliplatin: clinical features and risk factors.

Parel M, Ranchon F, Nosbaum A, You B, Vantard N, Schwiertz V, Gourc C, Gauthier N, Guedat MG, He S, Kiouris E, Alloux C, Vial T, Trillet-Lenoir V, Freyer G, Berard F, Rioufol C. Parel M, et al. BMC Pharmacol Toxicol. 2014 Jan 13;15:1. doi: 10.1186/2050-6511-15-1. BMC Pharmacol Toxicol. 2014. PMID: 24417770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters